Additional Study Information: The Breathe Easy Early ORBEX Study is a three -year study to identify if a daily capsule of Broncho-Vaxom may help prevent or delay young children from developing wheezing or asthma- like symptoms. Other studies have found that Broncho-Vaxom can help prevent upper respiratory infections and stimulate immune defenses, and has been safely and effectively used around the world. Broncho-Vaxom has not been approved yet in the United States however, it has been used safely by 43 million children in countries all over the world.